Pentaglobin as Early Adjuvant Treatment for Febrile Neutropenia in Acute Leukemia or Allogeneic Hematopoietic Stem Cell Transplant Patients Colonized by Carbapenem-resistant Enterobacteriaceae (CRE) or Pseudomonas Aeruginosa (PA)
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2019
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Febrile neutropenia
- Focus Therapeutic Use
- Acronyms PENTALLO
- 11 Nov 2019 Planned End Date changed from 1 Sep 2021 to 1 Dec 2021.
- 11 Nov 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2020.
- 11 Nov 2019 Planned initiation date changed from 1 Sep 2018 to 1 Dec 2019.